Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Huilai Zhang"'
Autor:
Jie Zha, Liyuan Fan, Shuhua Yi, Haifeng Yu, Zhong Zheng, Wei Xu, Manman Deng, Zhijuan Lin, Zhifeng Li, Lingyan Ping, Xiaohua He, Feili Chen, Ying Xie, Biyun Chen, Huilai Zhang, Li Wang, Kaiyang Ding, Wenyu Li, Haiyan Yang, Weili Zhao, Lugui Qiu, Zhiming Li, Yuqin Song, Bing Xu
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-4 (2021)
Abstract Clinical features and outcomes of FL patients in Chinese population are limited, thus promoting us to perform this analysis on a large cohort of 1845 patients with FL enrolled from nine medical centers nationwide in China. In this cohort, th
Externí odkaz:
https://doaj.org/article/9cf0341970c54b41a7eb7097cb766ce4
Autor:
Yuankai Shi, Bo Jia, Wei Xu, Wenyu Li, Ting Liu, Peng Liu, Weili Zhao, Huilai Zhang, Xiuhua Sun, Haiyan Yang, Xi Zhang, Jie Jin, Zhengming Jin, Zhiming Li, Lugui Qiu, Mei Dong, Xiaobing Huang, Yi Luo, Xiaodong Wang, Xin Wang, Jianqiu Wu, Jingyan Xu, Pingyong Yi, Jianfeng Zhou, Hongming He, Lin Liu, Jianzhen Shen, Xiaoqiong Tang, Jinghua Wang, Jianmin Yang, Qingshu Zeng, Zhihui Zhang, Zhen Cai, Xiequn Chen, Kaiyang Ding, Ming Hou, Huiqiang Huang, Xiaoling Li, Rong Liang, Qifa Liu, Yuqin Song, Hang Su, Yuhuan Gao, Lihong Liu, Jianmin Luo, Liping Su, Zimin Sun, Huo Tan, Huaqing Wang, Jingwen Wang, Shuye Wang, Hongyu Zhang, Xiaohong Zhang, Daobin Zhou, Ou Bai, Gang Wu, Liling Zhang, Yizhuo Zhang
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-5 (2017)
Abstract The efficacy and safety of chidamide, a new subtype-selective histone deacetylase (HDAC) inhibitor, have been demonstrated in a pivotal phase II clinical trial, and chidamide has been approved by the China Food and Drug Administration (CFDA)
Externí odkaz:
https://doaj.org/article/fb0461c9c99841929ebde75677646c99
Autor:
Lingling Zhou, Tong Liu, Ziliang Chen, Ke Lu, Huilai Zhang, Huayue Tao, Xue Han, Xiulian Li, Gary Tse, Daiqi Liu
Publikováno v:
Journal of Electrocardiology. 60:195-199
Patients receiving anthracycline-based chemotherapy (AbC) for newly diagnosed diffuse large B-cell lymphoma (DLBCL) may develop cardiac electrophysiological abnormalities. In this study, their electrocardiography (ECG) features were analyzed.Electron
Autor:
Yongping Song, Ting Liu, Donglu Zhao, Xiaobing Huang, Wei Xu, Guangxun Gao, Haiyan Yang, Jun Zhu, Jinghua Wang, Wei-Li Zhao, Qingqing Cai, Min Mao, Zhihui Zhang, Qingshu Zeng, Hongwei Xue, Kaiyang Ding, Jingyan Xu, Hang Su, Yuankai Shi, Ting Niu, Liling Zhang, Peng Liu, Hongyu Zhang, Jianzhen Shen, Lihong Liu, Huiqiang Huang, Jianfeng Zhou, Xiaojing Yan, Ru Feng, Jie Jin, Jianda Hu, Huilai Zhang, Xin Wang, Jun Ma, Huo Tan, Lugui Qiu, Bing Xu, Yu Yang, Daobin Zhou, Hui Zhou, Zhi-Xiang Shen, Ou Bai, Weiping Liu, Wenyu Li, Zhi Ming Li, Ming Hou
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
Chidamide has demonstrated significant clinical benefits for patients with relapsed/refractory (R/R) PTCL in previous studies. This multi-center observational study was aimed to evaluate the objective response rate (ORR), overall survival (OS), and s
Autor:
Lugui Qiu, Huilai Zhang, Zhifeng Li, Zhong Zheng, Kaiyang Ding, Zhi Ming Li, Feili Chen, Ying Xie, Li Wang, Haiyan Yang, Haifeng Yu, Bi-yun Chen, Wenyu Li, Zhijuan Lin, Liyuan Fan, Bing Xu, Manman Deng, Wei-Li Zhao, Lingyan Ping, Yuqin Song, Xiaohua He, Shuhua Yi, Jie Zha, Wei Xu
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-4 (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Clinical features and outcomes of FL patients in Chinese population are limited, thus promoting us to perform this analysis on a large cohort of 1845 patients with FL enrolled from nine medical centers nationwide in China. In this cohort, the median
Autor:
Qian Fan, Zhiqiang Ning, Huilai Zhang, Yuqin Song, Shiyu Jiang, Junning Cao, Jun Zhu, Dongmei Ji, Jia Yu, Lin Gui, Yuankai Shi
Publikováno v:
Chinese Journal of Cancer Research
Objective Chidamide is an oral histone deacetylase subtype-selective inhibitor approved for relapsed or refractory peripheral T-cell lymphoma (PTCL). This phase 1b study evaluated the safety, pharmacokinetics, and preliminary efficacy of chidamide in
Autor:
Jingwei Yu, Ou Bai, Xiuhua Sun, Wenchen Gong, Xiubao Ren, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Xianhuo Wang, Huilai Zhang, Tingting Zhang, Lanfang Li, Liping Su, Xue Guan, Yaxiao Lu, Hui Zhou, Bin Meng
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
PurposeAlthough the role of tumor-infiltrating T cells in follicular lymphoma (FL) has been reported previously, the prognostic value of peripheral blood T lymphocyte subsets has not been systematically assessed. Thus, we aim to incorporate T-cell su
Autor:
Zhengzi Qian, Xiubao Ren, Lanfang Li, Yuheng Hong, Lihua Qiu, Huilai Zhang, Shiyong Zhou, Xianhuo Wang, Qiqi Zhou, Ge Hu, Qingpei Guan
Publikováno v:
Hematological oncologyREFERENCES. 39(4)
This study aimed to identify the prognostic factors in patients with Waldeyer's ring diffuse large B-cell lymphoma (WR-DLBCL), comparing the efficacy of radiotherapy (RT) for the WR-DLBCL patients in the pre-rituximab and rituximab eras. We conducted
Publikováno v:
International Journal of Nanomedicine
Peiqi Zhao, Lihua Qiu, Shiyong Zhou, Lanfang Li, Zhengzi Qian, Huilai Zhang Department of Lymphoma, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianji
Publikováno v:
Hematological Oncology. 36:779-785
Interstitial pneumonia (IP) is one of the potentially fatal adverse events for lymphoma patients undergoing immunochemotherapy. However, the risk factors and predictive markers remain unclear for this complication. This retrospective study aims to ex